{
    "nctId": "NCT05265715",
    "briefTitle": "A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors",
    "officialTitle": "A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 14,
    "primaryOutcomeMeasure": "Feasibility as measured by adherence rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of breast cancer, any subtype, stage I-III, within the last 36 months, who have completed primary therapy of their breast cancer (surgery, radiation, and chemotherapy). Must be at least 4 weeks post their last chemotherapy or radiation therapy. Concurrent hormonal therapy is allowed.\n* At least 18 years of age.\n* Determined to have a high AGE diet at baseline (dietary AGE intake greater than 14 Eq/day as assessed by food frequency questionnaire).\n* Ability to understand and willingness to sign an IRB approved written informed consent document.\n\nExclusion Criteria:\n\n* Diagnosis of diabetes.\n* History of eating disorder or body dysmorphic disorder.\n* Active tobacco use (tobacco is a source of advanced glycation end products).\n* Active participation in other dietary or physical activity clinical trials or community interventions.\n* Taking and unwilling/unable to stop taking B-6 (pyridoxamine), B1 (thiamine) or metformin (all known AGE inhibitors).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}